Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EGFR mutations subset in Chinese lung squamous cell carcinoma patients.

Molecular medicine reports - 1 Jun 2018

Sun Ying, Yin Xin, Wen Miao-Miao, Zhang Jiao, Wang Xue-Jiao, Xia Jing-Hua, Zhang Yan-Ning, Zhang Zhi-Pei, Li Xiao-Fei

Abstract excerpt

Research has identified that epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) possess large benefits for adenocarcinoma (ADC), although little benefit for squamous cell carcinoma (SCC). The aim of the present study was to investigate the percentage of patients with SCC with the EGFR mutations subset and the benefits of EGFR TKIs in SCC. In the present study, the EGFR mutations subset was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Kaplan-Meier Estimate

Share to Neoplasm Grading

Share to Neoplasm Metastasis

Share to Neoplasm Staging

Share to Protein Kinase Inhibitors

Source

Open in PubMed Open full text

Identifiers

PMID: 29620244
DOI: 10.3892/mmr.2018.8859
PMCID: PMC5983943

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EGFR mutations subset in Chinese lung squamous cell carcinoma patients.PMID 29620244Read ↗

EGFR mutations in surgically resected fresh specimens from 697 consecutive Chinese patients with non-small cell lung cancer and their relationships with clinical features.Semantic proximity Read ↗

Clinical outcomes of EGFR-TKIs in advanced squamous cell lung cancer.Semantic proximity Read ↗

Epidermal Growth Factor Receptor Mutation Status and Response to Tyrosine Kinase Inhibitors in Advanced Chinese Female Lung Squamous Cell Carcinoma: A Retrospective StudySemantic proximity Read ↗

Response to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma with the Rare Epidermal Growth Factor Receptor Mutation S768I: a Retrospective Analysis and Literature Review.Semantic proximity Read ↗

Associations between epidermal growth factor receptor mutations and histological subtypes of lung adenocarcinoma according to the IASLC/ATS/ERS classification in Chinese patients.Semantic proximity Read ↗

Identification of EGFR kinase domain mutations among lung cancer patients in China: implication for targeted cancer therapy.Semantic proximity Read ↗

Epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) of Yunnan in southwestern China.Semantic proximity Read ↗

EGFR Gene Mutation and Methodological Evaluation in 399 Patients with Non-small Cell Lung Cancer.Semantic proximity Read ↗

EGFR mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?Semantic proximity Read ↗

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advanced Squamous Cell Lung Cancer.Semantic proximity Read ↗

Epidermal growth factor receptor gene mutation status in pure squamous-cell lung cancer in Chinese patients.Semantic proximity Read ↗

Efficacy and predictors of EGFR tyrosine kinase inhibitors in Chinese advanced lung adenocarcinoma: analyses of 253 cases from a single institute.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.